biotech · Locally Advanced Breast Cancer (LABC) · Mantle Cell Lymphoma
Beijing Luzhu Biopharmaceutical
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Beijing Zhifei Lvzhu is a biotech organization headquartered in CN. Primary therapeutic focus areas include Locally Advanced Breast Cancer (LABC), Mantle Cell Lymphoma, Systemic Lupus Erythematosus, Meningitis, Pneumococ
Beijing, CN HQ
2 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Beijing, CN
- Employees
- 2
- Programs
- 7
- Drugs
- 5
- Patents
- 0
pneumococcal disease prevention
Phase 3 · mab · Pneumococcal Vaccines
pneumococcal disease prevention for Pneumococcal Vaccines is a Phase 3 program (mab) at Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd with 1 ClinicalTrials.gov record(s).
Internal code S20210036-5
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Phase
- Phase 3
- Modality
- mab
- Indication
- Pneumococcal Vaccines
- Status
- active
- Trials
- 1